MSCs have been show to upregulate tumor growth by migrating to the developing intrahepatic cholangiocarcinoma via SDF-1/CXCR4 signaling pathway, and MMP2 molecular factor in human medulloblastoma. This evidence concerns the gene CXCR4 and medulloblastoma.